Science Funding in the United States: Agencies, Grants, and Resources

The United States funds scientific research through a network of federal agencies, private foundations, and university systems — each with distinct priorities, mechanisms, and eligibility rules. Understanding how that funding flows matters to researchers, institutions, and anyone trying to make sense of why certain fields advance faster than others. This page covers the major agencies, how grants actually work, the scenarios researchers most commonly encounter, and the decision points that determine which funding path makes sense.

Definition and scope

Federal science funding in the United States refers to taxpayer-backed appropriations directed toward basic research, applied research, and development activities — categories the Office of Management and Budget defines distinctly in Circular A-11. Basic research seeks fundamental knowledge without a specific application in mind. Applied research points toward a defined practical objective. Development translates both into products, systems, or operational methods.

The scale is substantial. The federal government invested approximately $200 billion in research and development in fiscal year 2023, according to figures compiled by the American Association for the Advancement of Science R&D Budget and Policy Program. Defense-related R&D accounts for roughly half of that total, while civilian agencies — led by the National Institutes of Health and the National Science Foundation — drive the bulk of non-defense basic and applied research. Private foundation grants and industry-sponsored contracts layer on top of federal dollars, but the federal share remains the structural backbone of the American research enterprise.

A full map of the federal research funding agencies shows the spread more clearly — from the NIH's biomedical focus to the Department of Energy's national laboratory network.

How it works

Federal grants move through a competition cycle that begins with a funding opportunity announcement and ends — if successful — with an award notice and the first transfer of funds to an institution. The core steps look like this:

1. Announcement. An agency publishes a solicitation, often called an RFA (Request for Applications) or PA (Program Announcement), describing eligible research areas, award ceilings, and review criteria.
2. Application. Principal investigators, almost always affiliated with an eligible institution, prepare a research plan, budget, and supporting documents. The NIH and NSF each maintain their own submission portals and formatting requirements.
3. Peer review. Independent scientists evaluate applications on scientific merit. NIH uses a two-tier review system — study sections for initial scoring, then an advisory council for funding recommendations. NSF uses program officers alongside ad-hoc and panel reviews.
4. Scoring and funding. NIH applications receive a percentile score; funding probability depends on the payline each institute sets based on available budget. NSF does not use percentile scoring; program officers make recommendations with more discretionary latitude.
5. Award and reporting. Funded grants carry ongoing reporting obligations, including annual progress reports and financial accountability to the sponsoring agency.

Applying for research grants involves considerably more logistical scaffolding than the five-step outline suggests — indirect cost negotiations, institutional sign-offs, and compliance certifications all precede a final submission.

Common scenarios

Three distinct situations account for most of what researchers encounter in the funding landscape.

Early-career investigators typically compete for mechanisms designed to establish independent research programs. NIH's R01 grant is the workhorse of biomedical funding, but the K-series career development awards and the R21 exploratory mechanism serve researchers building track records. NSF's CAREER award targets faculty in the first five years of their appointment, combining research funding with an educational component.

Established labs competing for renewal face a different pressure: demonstrating productivity on prior funding while proposing work that extends rather than simply repeats previous results. Renewal applications are evaluated alongside new submissions without preferential scoring at most agencies, which means a lab with 20 years of NIH support competes on the same basis as a first-time applicant.

Researchers seeking non-federal support turn to private foundations — the Simons Foundation, the Howard Hughes Medical Institute, the Wellcome Trust's U.S. programs, and hundreds of smaller disease-specific foundations — each with eligibility criteria, thematic priorities, and application processes entirely separate from federal systems. Private and foundation research funding covers these mechanisms in detail.

Decision boundaries

Choosing between funding mechanisms involves three practical distinctions that shape how researchers prioritize their effort.

Direct vs. indirect costs. Federal grants fund both the actual research costs (direct) and a negotiated fraction covering institutional overhead (indirect, or F&A costs). Indirect cost rates vary by institution — research-intensive universities commonly negotiate rates above 50 percent of modified total direct costs — which affects how much actual science a given award dollar supports.

Investigator-initiated vs. program-directed funding. Most NSF and NIH mechanisms are investigator-initiated: the researcher defines the question. Contracts and program-specific solicitations flip that relationship — the agency identifies a need and solicits responsive work. Investigator-initiated grants generally offer more intellectual freedom; directed programs offer more funding certainty for researchers whose work fits the priority area.

Single-PI vs. collaborative awards. NIH R01 grants are PI-centric. Larger mechanisms — Program Project grants (P01), Center grants (P50, P30), and NSF's collaborative research awards — require multi-investigator teams and bring proportionally greater administrative complexity. The science produced by research collaboration and partnerships often justifies that overhead, but the coordination costs are real.

The broader science landscape that funding supports — from types of scientific research to research ethics and integrity — can be explored across the reference resources available at National Science Authority.